A task-shared, collaborative care psychosocial intervention for improving depressive symptomatology among older adults in a socioeconomically deprived area of Brazil (PROACTIVE): a pragmatic, two-arm, parallel-group, cluster-randomised controlled trial.


Journal

The lancet. Healthy longevity
ISSN: 2666-7568
Titre abrégé: Lancet Healthy Longev
Pays: England
ID NLM: 101773309

Informations de publication

Date de publication:
10 2022
Historique:
received: 25 04 2022
revised: 05 08 2022
accepted: 09 08 2022
entrez: 6 10 2022
pubmed: 7 10 2022
medline: 12 10 2022
Statut: ppublish

Résumé

There is an urgent need to reduce the burden of depression among older adults in low-income and middle-income countries (LMICs). We aimed to evaluate the efficacy of a task-shared, collaborative care psychosocial intervention for improving recovery from depression in older adults in Brazil. PROACTIVE was a pragmatic, two-arm, parallel-group, cluster-randomised controlled trial conducted in Guarulhos, Brazil. Primary care clinics (clusters) were stratified by educational level and randomly allocated (1:1) to either enhanced usual care alone (control group) or to enhanced usual care plus the psychosocial intervention (intervention group), which involved a 17-week psychosocial programme based on psychoeducation and behavioural activation approaches. Individuals approached for the initial screening assessment were selected randomly from a list of individuals provided by the Health Secretariat of Guarulhos. Face-to-face baseline assessments were conducted among adults aged 60 years or older registered with one of the primary care clinics and identified with clinically significant depressive symptomatology (9-item Patient Health Questionnaire [PHQ-9] score ≥10). Community health workers delivered the programme through home sessions, supported by a dedicated tablet application. Masking of clinic staff and community health workers who delivered the intervention was not feasible; however, research assistants conducting recruitment and follow-up assessments were masked to trial allocation. The primary outcome was recovery from depression (PHQ-9 score <10) at 8-month follow-up. All primary analyses were performed by intention to treat with imputed data. Adaptations to the protocol were made due to the COVID-19 pandemic; recruitment and intervention home sessions were stopped, and follow-up assessments were conducted by telephone. This trial is registered with the ISRCTN registry, ISRCTN57805470. We identified 24 primary care clinics in Guarulhos that were willing to participate, of which 20 were randomly allocated to either the control group (ten [50%] clusters) or to the intervention group (ten [50%] clusters). The four remaining eligible clusters were kept as reserves. Between May 23, 2019, and Feb 21, 2020, 8146 individuals were assessed for eligibility, of whom 715 (8·8%) participants were recruited: 355 (49·7%) in the control group and 360 (50·3%) in the intervention group. 284 (80·0%) participants in the control group and 253 (70·3%) in the intervention group completed follow-up at 8 months. At 8-month follow-up, 158 (62·5%) participants in the intervention group showed recovery from depression (PHQ-9 score <10) compared with 125 (44·0%) in the control group (adjusted odds ratio 2·16 [95% CI 1·47-3·18]; p<0·0001). These findings were maintained in the complete case analysis. No adverse events related to the intervention were observed. Although the COVID-19 pandemic altered delivery of the intervention, the low-intensity psychosocial intervention delivered mainly by non-mental health professionals was highly efficacious in improving recovery from depression in older adults in Brazil. Our results support a low-resource intervention that could be useful to reduce the treatment gap for depression among older people in other LMICs. São Paulo Research Foundation and Joint Global Health Trials (UK Department for International Development, Medical Research Council, and the Wellcome Trust).

Sections du résumé

BACKGROUND
There is an urgent need to reduce the burden of depression among older adults in low-income and middle-income countries (LMICs). We aimed to evaluate the efficacy of a task-shared, collaborative care psychosocial intervention for improving recovery from depression in older adults in Brazil.
METHODS
PROACTIVE was a pragmatic, two-arm, parallel-group, cluster-randomised controlled trial conducted in Guarulhos, Brazil. Primary care clinics (clusters) were stratified by educational level and randomly allocated (1:1) to either enhanced usual care alone (control group) or to enhanced usual care plus the psychosocial intervention (intervention group), which involved a 17-week psychosocial programme based on psychoeducation and behavioural activation approaches. Individuals approached for the initial screening assessment were selected randomly from a list of individuals provided by the Health Secretariat of Guarulhos. Face-to-face baseline assessments were conducted among adults aged 60 years or older registered with one of the primary care clinics and identified with clinically significant depressive symptomatology (9-item Patient Health Questionnaire [PHQ-9] score ≥10). Community health workers delivered the programme through home sessions, supported by a dedicated tablet application. Masking of clinic staff and community health workers who delivered the intervention was not feasible; however, research assistants conducting recruitment and follow-up assessments were masked to trial allocation. The primary outcome was recovery from depression (PHQ-9 score <10) at 8-month follow-up. All primary analyses were performed by intention to treat with imputed data. Adaptations to the protocol were made due to the COVID-19 pandemic; recruitment and intervention home sessions were stopped, and follow-up assessments were conducted by telephone. This trial is registered with the ISRCTN registry, ISRCTN57805470.
FINDINGS
We identified 24 primary care clinics in Guarulhos that were willing to participate, of which 20 were randomly allocated to either the control group (ten [50%] clusters) or to the intervention group (ten [50%] clusters). The four remaining eligible clusters were kept as reserves. Between May 23, 2019, and Feb 21, 2020, 8146 individuals were assessed for eligibility, of whom 715 (8·8%) participants were recruited: 355 (49·7%) in the control group and 360 (50·3%) in the intervention group. 284 (80·0%) participants in the control group and 253 (70·3%) in the intervention group completed follow-up at 8 months. At 8-month follow-up, 158 (62·5%) participants in the intervention group showed recovery from depression (PHQ-9 score <10) compared with 125 (44·0%) in the control group (adjusted odds ratio 2·16 [95% CI 1·47-3·18]; p<0·0001). These findings were maintained in the complete case analysis. No adverse events related to the intervention were observed.
INTERPRETATION
Although the COVID-19 pandemic altered delivery of the intervention, the low-intensity psychosocial intervention delivered mainly by non-mental health professionals was highly efficacious in improving recovery from depression in older adults in Brazil. Our results support a low-resource intervention that could be useful to reduce the treatment gap for depression among older people in other LMICs.
FUNDING
São Paulo Research Foundation and Joint Global Health Trials (UK Department for International Development, Medical Research Council, and the Wellcome Trust).

Identifiants

pubmed: 36202129
pii: S2666-7568(22)00194-5
doi: 10.1016/S2666-7568(22)00194-5
pmc: PMC9529612
pii:
doi:

Banques de données

ISRCTN
['ISRCTN57805470']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e690-e702

Subventions

Organisme : Medical Research Council
ID : MR/R006229/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licence. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

Lancet Glob Health. 2019 Jul;7(7):e951-e960
pubmed: 31097414
Stat Methods Med Res. 2013 Dec;22(6):661-70
pubmed: 22072596
Eur J Health Econ. 2013 Jul;14 Suppl 1:S1-3
pubmed: 23900659
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
JAMA. 2016 Dec 27;316(24):2618-2626
pubmed: 28027368
Lancet. 2008 Sep 13;372(9642):902-9
pubmed: 18790313
Arch Intern Med. 2006 Nov 27;166(21):2314-21
pubmed: 17130383
JAMA. 2002 Dec 11;288(22):2836-45
pubmed: 12472325
JAMA Psychiatry. 2019 Jan 1;76(1):13-20
pubmed: 30422259
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
JAMA. 2021 Jul 20;326(3):257-265
pubmed: 34152382
Aging Ment Health. 2021 Aug 19;:1-6
pubmed: 34409909
BMC Med. 2009 Dec 16;7:79
pubmed: 20015347
Qual Life Res. 2016 Feb;25(2):323-333
pubmed: 26242249
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
BMC Public Health. 2019 Aug 22;19(1):1152
pubmed: 31438903
Health Technol Assess. 2017 Nov;21(67):1-252
pubmed: 29171379
Trials. 2020 Nov 5;21(1):914
pubmed: 33153482
Int J Equity Health. 2016 Nov 17;15(1):154
pubmed: 27852278
PLoS One. 2014 Jun 17;9(6):e100100
pubmed: 24936656
J Sch Psychol. 2017 Feb;60:7-24
pubmed: 28164801
Soc Sci Med. 2006 Apr;62(8):1891-901
pubmed: 16168542
BMC Public Health. 2021 Dec 14;21(1):2278
pubmed: 34903192
JAMA. 2021 May 11;325(18):1852-1862
pubmed: 33974019
J Med Internet Res. 2019 Nov 12;21(11):e11346
pubmed: 31714246
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Value Health Reg Issues. 2022 Jul;30:91-99
pubmed: 35325703

Auteurs

Marcia Scazufca (M)

Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil; Departamento de Psiquiatria, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Carina A Nakamura (CA)

Departamento de Psiquiatria, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Nadine Seward (N)

Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Darío Moreno-Agostino (D)

Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; ESRC Centre for Society and Mental Health, King's College London, London, UK; Centre for Longitudinal Studies, Social Research Institute, University College London, London, UK.

Pepijn van de Ven (P)

Health Research Institute, University of Limerick, Limerick, Ireland.

William Hollingworth (W)

Health Economics Bristol, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Tim J Peters (TJ)

Bristol Dental School, University of Bristol, Bristol, UK.

Ricardo Araya (R)

Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: ricardo.araya@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH